280 results
Page 2 of 14
S-1/A
rjb4mlz 1kv2r
8 Apr 20
IPO registration (amended)
3:41pm
S-3
tmdrecs 9glc7bj
27 Mar 20
Shelf registration
4:51pm
S-1
l9n951j7z76k uvsjdo0
27 Mar 20
IPO registration
4:31pm
10-K
sk939l2uauhhv0ur2p4
27 Mar 20
Annual report
3:47pm
8-K
EX-99.1
arhyh6t1rf9co1ts
16 Mar 20
Precipio Completes the Transaction with Poplar Healthcare’s Oncometrix Hematopathology Division
4:17pm
8-K
EX-99.1
rx6aspycc l45k
18 Feb 20
Precipio in advanced discussions with Poplar Healthcare towards a multi-faceted strategic partnership
4:00pm
424B3
4vwkw9l
30 Jan 20
Prospectus supplement
5:09pm
S-1/A
gujz0vqwewortw pk8
27 Jan 20
IPO registration (amended)
4:47pm
S-1
2lfpwghuyk yjbzahjyf
14 Jan 20
IPO registration
4:26pm
10-Q
1lit80bzzp aks
13 Nov 19
Quarterly report
4:33pm
8-K
EX-99.1
apka8 tdm9i6zk
26 Sep 19
Clinical Validations for IV-Cell™ and HemeScreen™ Completed
4:43pm
424B3
11q4ho8yto6ht1400pt2
21 Aug 19
Prospectus supplement
5:28pm
S-1
1av50olmbq38v36wo
9 Aug 19
IPO registration
3:47pm
10-Q
8j3nfyurvvf 0ea3
9 Aug 19
Quarterly report
2:55pm
8-K
EX-99.1
pqd55vt7n 61i9o409d4
20 Jun 19
Precipio CEO Provides Update Letter To Shareholders
5:03pm
10-Q
wkb03ucdcn 5t1
16 May 19
Quarterly report
4:02pm
10-Q
EX-10.3
uh262t2fq49dhv
16 May 19
Quarterly report
4:02pm
10-K
5blifp6b2b0terc2a
16 Apr 19
Annual report
5:20pm
424B3
kyipqxbd8
13 Feb 19
Prospectus supplement
5:01pm
S-1
etjyrwp s2y
1 Feb 19
IPO registration
3:36pm